Key Points HIV-Associated Tuberculosis Almost half of inpatients with human
immunodeficiency virus (HIV)–associated tuberculosis in countries with a high disease …

Great progress has been made over the past half-century, but TB remains a formidable
global health problem, particularly in low-and middle-income countries. Understanding the …

Non-sputum tests are needed to improve tuberculosis (TB) diagnosis and close the
diagnostic gap. The World Health Organization's target product profile (TPP) for point-of-care …

Background CD4 measurement is pivotal in the management of advanced human
immunodeficiency virus (HIV) disease. VISITECT CD4 Advanced Disease (VISITECT; …

Fluorescent‐magneto nanoemitters have gained considerable attention for their applications
in mechanical controlling‐assisted optical signaling. However, the incompatibility between …

Purpose This study aimed to assess the efficacy of chemiluminescence-based urinary
lipoarabinomannan (LAM) antigen assay as a diagnostic tool for identifying active …

Better access to tuberculosis testing is a key priority for fighting tuberculosis, the leading
cause of infectious disease deaths in people. Despite the roll-out of molecular WHO …

Background Diagnostic delays for tuberculosis are common, with high resultant mortality.
Urine-Xpert Ultra (Cepheid) could improve time to diagnosis of tuberculosis disease and …

Background Development of a non-sputum test using readily-obtainable biospecimens
remains a global priority for tuberculosis (TB) control. We quantified lipoarabinomannan …

Recent years have witnessed key developments in the diagnosis and treatment of
tuberculosis. Alongside this, and running in direct opposition to this progress, was the …